Carboplatin Inhibits the Progression of Retinoblastoma Through IncRNA XIST/miR-200a-3p/NRP1 Axis

Hong Zhao,1 Jingjing Wan,1 Yu Zhu2 1Department of Ophthalmic Outpatient, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, Henan Province, People’s Republic of China; 2The Fifth Department of Ophthalmology, The First Affiliated Hospital of Zhengzhou University, Zheng...

Full description

Bibliographic Details
Main Authors: Zhao H, Wan J, Zhu Y
Format: Article
Language:English
Published: Dove Medical Press 2020-08-01
Series:Drug Design, Development and Therapy
Subjects:
Online Access:https://www.dovepress.com/carboplatin-inhibits-the-progression-of-retinoblastoma-through-incrna--peer-reviewed-article-DDDT
id doaj-1a1012cea93e4905a6235846c19fa720
record_format Article
spelling doaj-1a1012cea93e4905a6235846c19fa7202020-11-25T03:51:45ZengDove Medical PressDrug Design, Development and Therapy1177-88812020-08-01Volume 143417342756456Carboplatin Inhibits the Progression of Retinoblastoma Through IncRNA XIST/miR-200a-3p/NRP1 AxisZhao HWan JZhu YHong Zhao,1 Jingjing Wan,1 Yu Zhu2 1Department of Ophthalmic Outpatient, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, Henan Province, People’s Republic of China; 2The Fifth Department of Ophthalmology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, Henan Province, People’s Republic of ChinaCorrespondence: Yu ZhuThe Fifth Department of Ophthalmology, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Zhengzhou 450003, Henan Province, People’s Republic of ChinaEmail gf20191127@126.comObjective: This study was set out to explore the expression and related mechanism of XIST and miR-200a-3p in retinoblastoma (Rb).Patients and Methods: Fifty-four children with Rb who came to our hospital for surgery from January 2018 to September 2019 were collected. In addition, Rb cells and human retinal epithelial cells were purchased. XIST-siRNA (si-XIST), XIST-shRNA (sh-XIST), empty vector plasmid (siRNA-NC), miR-200a-3p-mimics and miR − 200a-3p-inhibition were transfected into Y79 cells. The expression of XIST and miR-200a-3p in the samples were determined by qRT-PCR. β-catenin, cyclin B1, cyclin D1, Bax, Caspase-3, N-cadherin, vimentin, Snail, E-Cadherin and ZO-1 protein levels were measured by WB. MTT, Transwell and flow cytometry were utilized to detect cell proliferation, invasion, and apoptosis, respectively.Results: XIST was highly expressed while miR-200a-3p was lowly expressed in patients’ tissues, and the AUC of both was over 0.8. XIST and miR-200a-3p was related to differentiation degree in Rb patients. Y79 cells were selected for transfection. Compared with the siRNA-NC group, XIST was significantly reduced in the siRNA-XIST group, and it was significantly increased in the shRNA-XIST group (P< 0.01). The proliferation capacity of siRNA-XIST group was decreased, while that of shRNA-XIST group was up-regulated. The apoptosis rate of siRNA-XIST group was significantly up-regulated, while that of shRNA-XIST group was decreased (P< 0.001). The invasive capacity of siRNA-XIST group was decreased, while that of shRNA-XIST group was up-regulated (P< 0.001). Silencing XIST and over-expressed miR-200a-3p could inhibit cell epithelial–mesenchymal transition (EMT), proliferation, invasion, and promote apoptosis. WB detection showed that Carboplatin + LncRNA XIST intervention group could more significantly inhibit β-catenin, cyclin B1, cyclin D1, N-cadherin, vimentin, Snail protein, and promote the up-regulation of Bax, Caspase-3, E-Cadherin and ZO-1 expression.Conclusion: Inhibition of XIST expression can up-regulate miR-200a-3p-mediated PI3K-Akt/MAPK-ERK signaling pathway and affect cell EMT, proliferation, invasion, and apoptosis, which is expected to be a potential therapeutic target for Rb.Keywords: lncRNA-XIST, miR-200a-3p, NRP1, epithelial–mesenchymal transition, retinoblastoma, biological mechanismhttps://www.dovepress.com/carboplatin-inhibits-the-progression-of-retinoblastoma-through-incrna--peer-reviewed-article-DDDTlncrna-xistmir-200a-3pnrp1epithelial-mesenchymal transitionretinoblastomabiological mechanism
collection DOAJ
language English
format Article
sources DOAJ
author Zhao H
Wan J
Zhu Y
spellingShingle Zhao H
Wan J
Zhu Y
Carboplatin Inhibits the Progression of Retinoblastoma Through IncRNA XIST/miR-200a-3p/NRP1 Axis
Drug Design, Development and Therapy
lncrna-xist
mir-200a-3p
nrp1
epithelial-mesenchymal transition
retinoblastoma
biological mechanism
author_facet Zhao H
Wan J
Zhu Y
author_sort Zhao H
title Carboplatin Inhibits the Progression of Retinoblastoma Through IncRNA XIST/miR-200a-3p/NRP1 Axis
title_short Carboplatin Inhibits the Progression of Retinoblastoma Through IncRNA XIST/miR-200a-3p/NRP1 Axis
title_full Carboplatin Inhibits the Progression of Retinoblastoma Through IncRNA XIST/miR-200a-3p/NRP1 Axis
title_fullStr Carboplatin Inhibits the Progression of Retinoblastoma Through IncRNA XIST/miR-200a-3p/NRP1 Axis
title_full_unstemmed Carboplatin Inhibits the Progression of Retinoblastoma Through IncRNA XIST/miR-200a-3p/NRP1 Axis
title_sort carboplatin inhibits the progression of retinoblastoma through incrna xist/mir-200a-3p/nrp1 axis
publisher Dove Medical Press
series Drug Design, Development and Therapy
issn 1177-8881
publishDate 2020-08-01
description Hong Zhao,1 Jingjing Wan,1 Yu Zhu2 1Department of Ophthalmic Outpatient, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, Henan Province, People’s Republic of China; 2The Fifth Department of Ophthalmology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, Henan Province, People’s Republic of ChinaCorrespondence: Yu ZhuThe Fifth Department of Ophthalmology, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Zhengzhou 450003, Henan Province, People’s Republic of ChinaEmail gf20191127@126.comObjective: This study was set out to explore the expression and related mechanism of XIST and miR-200a-3p in retinoblastoma (Rb).Patients and Methods: Fifty-four children with Rb who came to our hospital for surgery from January 2018 to September 2019 were collected. In addition, Rb cells and human retinal epithelial cells were purchased. XIST-siRNA (si-XIST), XIST-shRNA (sh-XIST), empty vector plasmid (siRNA-NC), miR-200a-3p-mimics and miR − 200a-3p-inhibition were transfected into Y79 cells. The expression of XIST and miR-200a-3p in the samples were determined by qRT-PCR. β-catenin, cyclin B1, cyclin D1, Bax, Caspase-3, N-cadherin, vimentin, Snail, E-Cadherin and ZO-1 protein levels were measured by WB. MTT, Transwell and flow cytometry were utilized to detect cell proliferation, invasion, and apoptosis, respectively.Results: XIST was highly expressed while miR-200a-3p was lowly expressed in patients’ tissues, and the AUC of both was over 0.8. XIST and miR-200a-3p was related to differentiation degree in Rb patients. Y79 cells were selected for transfection. Compared with the siRNA-NC group, XIST was significantly reduced in the siRNA-XIST group, and it was significantly increased in the shRNA-XIST group (P< 0.01). The proliferation capacity of siRNA-XIST group was decreased, while that of shRNA-XIST group was up-regulated. The apoptosis rate of siRNA-XIST group was significantly up-regulated, while that of shRNA-XIST group was decreased (P< 0.001). The invasive capacity of siRNA-XIST group was decreased, while that of shRNA-XIST group was up-regulated (P< 0.001). Silencing XIST and over-expressed miR-200a-3p could inhibit cell epithelial–mesenchymal transition (EMT), proliferation, invasion, and promote apoptosis. WB detection showed that Carboplatin + LncRNA XIST intervention group could more significantly inhibit β-catenin, cyclin B1, cyclin D1, N-cadherin, vimentin, Snail protein, and promote the up-regulation of Bax, Caspase-3, E-Cadherin and ZO-1 expression.Conclusion: Inhibition of XIST expression can up-regulate miR-200a-3p-mediated PI3K-Akt/MAPK-ERK signaling pathway and affect cell EMT, proliferation, invasion, and apoptosis, which is expected to be a potential therapeutic target for Rb.Keywords: lncRNA-XIST, miR-200a-3p, NRP1, epithelial–mesenchymal transition, retinoblastoma, biological mechanism
topic lncrna-xist
mir-200a-3p
nrp1
epithelial-mesenchymal transition
retinoblastoma
biological mechanism
url https://www.dovepress.com/carboplatin-inhibits-the-progression-of-retinoblastoma-through-incrna--peer-reviewed-article-DDDT
work_keys_str_mv AT zhaoh carboplatininhibitstheprogressionofretinoblastomathroughincrnaxistmir200a3pnrp1axis
AT wanj carboplatininhibitstheprogressionofretinoblastomathroughincrnaxistmir200a3pnrp1axis
AT zhuy carboplatininhibitstheprogressionofretinoblastomathroughincrnaxistmir200a3pnrp1axis
_version_ 1724485795536961536